Sustained remission of treatment-resistant cutaneous T-cell lymphoma with oral bexarotene

被引：0
|
作者：
Mehlmauer, MA [1 ]
机构：
[1] Huntington Mem Hosp, Pasadena, CA USA
来源：
CUTIS | 2004年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Cutaneous T-cell lymphomas (CTCL) encompass a spectrum of clinical and histologic variants, characterized by malignant CD4+ T lymphocytes in the skin and visceral organs. This is a case report of a 74-year-old man with CTCL, including ulcerative lesions, resistant to multiple systemic therapies. Treatment with oral bexarotene resulted in rapid and sustained remission of both cutaneous and systemic symptoms.
引用
收藏
页码：417 / 420
页数：4
相关论文
共 50 条
  • [31] Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis
    Demierre, Marie-France
    Ferzli, Pascal
    Miller, Donald
    ARCHIVES OF DERMATOLOGY, 2007, 143 (05) : 659 - 661
  • [32] Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
    Assaf, C.
    Bagot, M.
    Dummer, R.
    Duvic, M.
    Gniadecki, R.
    Knobler, R.
    Ranki, A.
    Schwandt, P.
    Whittaker, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (02) : 261 - 266
  • [33] ORAL MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA
    KASHA, EE
    PARKER, CM
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1990, 29 (04) : 275 - 280
  • [34] TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    BUNN, PA
    CARNEY, DN
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1980, 6 (05): : 383 - 387
  • [35] TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    ZACKHEIM, HS
    SEMINARS IN DERMATOLOGY, 1994, 13 (03): : 207 - 215
  • [36] TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    VONDERHEID, EC
    MICAILY, B
    DERMATOLOGIC CLINICS, 1985, 3 (04) : 673 - 687
  • [37] New insights into the mechanism of action of bexarotene in human cutaneous T-cell lymphoma
    Asumendi, A.
    Nieto-Rementeria, N.
    Izu, R.
    Pérez-Yarza, G.
    Boyano, M. D.
    Ratón, J. A.
    Apraiz, A.
    Díaz-Pérez, J. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 64 - 64
  • [38] Inhibition of the integrin αVβ3 improves the effect of bexarotene in the treatment of cutaneous T-cell lymphoma (CTCL)
    Cayrol, Florencia
    Revueta, Victoria
    Paulazo, Alejandra
    Debernardi, Mercedes
    Flaque, Maria Celeste Diaz
    Sterle, Helena
    Cerchietti, Leandro
    Cremaschi, Graciela
    CANCER RESEARCH, 2017, 77
  • [39] REMISSION OF CUTANEOUS T-CELL LYMPHOMA WITH COMBINED CALCITRIOL AND ACITRETIN
    FRENCH, LE
    RAMELET, AA
    SAURAT, JH
    LANCET, 1994, 344 (8923): : 686 - 687
  • [40] Bexarotene: a registry study of adverse effects in a population of patients with cutaneous T-cell lymphoma
    Shukur, Z.
    Morgans, C.
    Wain, E. M.
    Morris, S.
    Whittaker, S.
    Child, F. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 71 - 71
12345